Literature DB >> 21833019

HLA alleles and amino-acid signatures of the peptide-binding pockets of HLA molecules in vitiligo.

Archana Singh1, Pankaj Sharma, Hemanta K Kar, Vinod K Sharma, Manoj K Tembhre, Somesh Gupta, Naresh C Laddha, Mitesh Dwivedi, Rasheedunnisa Begum, Rajesh S Gokhale, Rajni Rani.   

Abstract

Vitiligo is a depigmenting disorder of the skin that is characterized by the loss of functional melanocytes from the lesional sites. Although the exact etiology is not understood, autoimmunity is thought to be a crucial deterministic factor. A recurring theme of several autoimmune disorders is the aberrant presentation of self-antigens to the immune system, which triggers downstream perturbations. Here we examine the role of alleles of HLA class I and class II loci to delineate vitiligo manifestation in two distinct populations. Our studies have identified three specific alleles, HLA-A*33:01, HLA-B*44:03, and HLA-DRB1*07:01, to be significantly increased in vitiligo patients as compared with controls in both the initial study on North Indians (N=1,404) and the replication study in Gujarat (N=355) cases, establishing their positive association with vitiligo. Both generalized and localized vitiligo have the same predisposing major histocompatibility complex alleles, i.e., B*44:03 and DRB1*07:01, in both the populations studied, beside the differences in the frequencies of other alleles, suggesting that localized vitiligo too may be an autoimmune disorder. Significant differences in the amino-acid signatures of the peptide-binding pockets of HLA-A and HLA-B α-chain and HLA-DR β-chain were observed between vitiligo patients and unaffected controls.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21833019     DOI: 10.1038/jid.2011.240

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  26 in total

Review 1.  Genetics of Vitiligo.

Authors:  Richard A Spritz; Genevieve H L Andersen
Journal:  Dermatol Clin       Date:  2017-04       Impact factor: 3.478

Review 2.  Multifaceted pathways protect human skin from UV radiation.

Authors:  Vivek T Natarajan; Parul Ganju; Amrita Ramkumar; Ritika Grover; Rajesh S Gokhale
Journal:  Nat Chem Biol       Date:  2014-07       Impact factor: 15.040

3.  Lsr2 of Mycobacterium leprae and its synthetic peptides elicit restitution of T cell responses in erythema nodosum leprosum and reversal reactions in patients with lepromatous leprosy.

Authors:  Chaman Saini; H K Prasad; Rajni Rani; A Murtaza; Namita Misra; N P Shanker Narayan; Indira Nath
Journal:  Clin Vaccine Immunol       Date:  2013-02-27

4.  Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized vitiligo.

Authors:  Mitesh Dwivedi; Naresh C Laddha; Kriti Shah; Bela J Shah; Rasheedunnisa Begum
Journal:  J Interferon Cytokine Res       Date:  2013-06-18       Impact factor: 2.607

5.  Risk factors and characterization of vitiligo and alopecia areata in patients with chronic graft-vs-host disease.

Authors:  Rena C Zuo; Haley B Naik; Seth M Steinberg; Kristin Baird; Sandra A Mitchell; Zoya Kuzmina; Steven Z Pavletic; Edward W Cowen
Journal:  JAMA Dermatol       Date:  2015-01       Impact factor: 10.282

6.  The Secreted Protein Rv1860 of Mycobacterium tuberculosis Stimulates Human Polyfunctional CD8+ T Cells.

Authors:  Vijaya Satchidanandam; Naveen Kumar; Sunetra Biswas; Rajiv S Jumani; Chandni Jain; Rajni Rani; Bharti Aggarwal; Jaya Singh; Mohan Rao Kotnur; Anand Sridharan
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

7.  Tumor necrosis factor B (TNFB) genetic variants and its increased expression are associated with vitiligo susceptibility.

Authors:  Naresh C Laddha; Mitesh Dwivedi; Amina R Gani; Mohmmad Shoab Mansuri; Rasheedunnisa Begum
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

Review 8.  Vitiligo--part 1.

Authors:  Roberto Gomes Tarlé; Liliane Machado do Nascimento; Marcelo Távora Mira; Caio Cesar Silva de Castro
Journal:  An Bras Dermatol       Date:  2014 May-Jun       Impact factor: 1.896

9.  Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo.

Authors:  Naresh C Laddha; Mitesh Dwivedi; Rasheedunnisa Begum
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

10.  Association of generalized vitiligo with MHC class II loci in patients from the Indian subcontinent.

Authors:  Stanca A Birlea; Fridoon J Ahmad; Raza M Uddin; Shakil Ahmad; Sabrina S Pal; Rasheedunnisa Begum; Naresh C Laddha; Mitesh Dwivedi; Mohmmad Shoab Mansuri; Ying Jin; Katherine Gowan; Sheri L Riccardi; Paulene J Holland; Songtao Ben; Pamela R Fain; Richard A Spritz
Journal:  J Invest Dermatol       Date:  2013-01-10       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.